Company Quick10K Filing
CLS Holdings
10-Q 2020-02-29 Filed 2020-04-14
10-Q 2019-11-30 Filed 2020-01-14
10-Q 2019-08-31 Filed 2019-10-15
S-1 2019-07-03 Public Filing
10-K 2019-05-31 Filed 2019-08-29
S-1 2019-03-28 Public Filing
10-Q 2019-02-28 Filed 2019-04-15
10-Q 2018-11-30 Filed 2019-01-14
10-Q 2018-08-31 Filed 2018-10-12
S-1 2018-08-29 Public Filing
S-1 2018-08-29 Public Filing
10-K 2018-05-31 Filed 2018-08-29
10-Q 2018-02-28 Filed 2018-04-16
10-Q 2017-11-30 Filed 2018-01-12
10-Q 2017-08-31 Filed 2017-10-13
10-K 2017-05-31 Filed 2017-08-29
10-Q 2017-02-28 Filed 2017-04-12
10-Q 2016-11-30 Filed 2017-01-17
10-Q 2016-08-31 Filed 2016-10-17
10-K 2016-05-31 Filed 2016-08-29
10-Q 2016-02-29 Filed 2016-04-12
10-Q 2015-11-30 Filed 2016-01-14
10-Q 2015-08-31 Filed 2015-10-13
10-K 2015-05-31 Filed 2015-08-28
10-Q 2015-02-28 Filed 2015-04-13
10-Q 2014-11-30 Filed 2015-01-14
10-Q 2014-08-31 Filed 2014-10-15
10-K 2014-05-31 Filed 2014-08-29
10-Q 2014-02-28 Filed 2014-04-14
10-Q 2013-11-30 Filed 2014-01-14
10-Q 2013-08-31 Filed 2013-10-15
8-K 2020-04-16 Officers
8-K 2020-04-02 Regulation FD, Exhibits
8-K 2020-03-09 Regulation FD
8-K 2019-12-16 Officers
8-K 2019-10-03 Regulation FD, Exhibits
8-K 2019-08-29 Earnings, Exhibits
8-K 2019-07-26 Enter Agreement, Exhibits
8-K 2019-06-04 Shareholder Vote
8-K 2019-05-01 Officers
8-K 2019-04-16 Earnings, Exhibits
8-K 2019-03-11 Enter Agreement, Exhibits
8-K 2019-03-01 Enter Agreement, Officers, Other Events, Exhibits
8-K 2019-02-28 Other Events, Exhibits
8-K 2019-01-29 Enter Agreement, Exhibits
8-K 2018-12-31 Regulation FD, Exhibits
8-K 2018-12-12 Regulation FD, Exhibits
8-K 2018-12-12 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-10-31 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-10-05 Regulation FD, Other Events, Exhibits
8-K 2018-10-03 Regulation FD, Exhibits
8-K 2018-08-08 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-08-06 Enter Agreement, Exhibits
8-K 2018-07-31 Enter Agreement, Officers, Exhibits
8-K 2018-07-31 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-07-24 Enter Agreement, Leave Agreement, Officers, Exhibits
8-K 2018-07-20 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-06-28 Enter Agreement, Exhibits
8-K 2018-06-27 M&A, Off-BS Arrangement, Exhibits
8-K 2018-06-20 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-05-17 Enter Agreement, Exhibits
8-K 2018-05-11 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-05-08 Regulation FD, Other Events, Exhibits
8-K 2018-04-06 Enter Agreement, Exhibits
8-K 2018-04-02 Enter Agreement, Exhibits
8-K 2018-02-20 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-02-12 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-02-06 Sale of Shares
8-K 2018-02-05 Enter Agreement, Off-BS Arrangement, Sale of Shares, Exhibits
8-K 2018-01-25 Enter Agreement, Exhibits
8-K 2018-01-16 Enter Agreement, Exhibits
8-K 2018-01-10 Enter Agreement, Exhibits
8-K 2018-01-05 Enter Agreement, Exhibits
8-K 2018-01-03 Regulation FD, Exhibits

CLS Holdings Financials

CLSH Metrics, Comps, Filings

Quarterly | Annual

Business

We were originally incorporated as Adelt Design, Inc. on March 31, 2011 to manufacture and market carpet binding art. Production and marketing of carpet binding art never commenced. After CLS Labs, Inc. ("CLS Labs") acquired 55.6% of the outstanding shares of Common Stock of the Company, Jeffrey Binder, the Chairman, President and Chief Executive Officer of CLS Labs, was appointed Chairman, President and Chief Executive Officer of the Company. Subsequently, the Company adopted amended and restated articles of incorporation, thereby changing its name to CLS Holdings USA, Inc.

On April 29, 2015, the Company entered into a merger agreement with CLS Labs and a newly-formed, wholly owned subsidiary of the Company (the "Merger Sub") and effected the Merger (the "Merger"). Upon the consummation of the Merger, the separate existence of the Merger Sub ceased and CLS Labs, the surviving corporation in the Merger, became a wholly owned subsidiary of the Company, with the Company acquiring the stock of CLS Labs, abandoning its previous business, and adopting the existing business plan and operations of CLS Labs. CLS Labs is a company that plans to generate revenues through licensing, fee-for-service and joint venture arrangements related to its patented proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into saleable concentrates.

Since 2014, one of the founders of CLS Labs has been developing a proprietary method of extracting cannabinoids from cannabis plants and converting the resulting cannabinoid extracts into concentrates such as oils, waxes, edibles and shatter. These concentrates may be ingested in a number of ways, including through vaporization via e-cigarettes, and used for a variety of pharmaceutical and other purposes. Internal testing of the cannabinoids extracted through our patent-pending proprietary process versus the cannabinoids resulting from the processes commonly used in the industry, the results of which were reviewed and confirmed by an independent laboratory, has revealed that our process produces a cleaner, higher quality product and a significantly higher yield than the cannabinoid extraction processes currently existing in the marketplace.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Postads (PTAD) 0% 0.0 -19,225% 1 492 0 0 -117 -116 -1
CLS Holdings (CLSH) 43% -0.5 -59% 46,503 21,466 8,459 3,623 -27,619 -22,883 11,834
Shoal Games (SGLDF) 37% 0.6 -6% 22,615 838 2,395 889 -1,284 -1,370 -812
Image International Group (IMAGE) 0% 0.3 -29% 2,698 4,737 9 0 -777 -734 -246
Wells Fargo Real Estate Investment (WFE) -0.5 3% 32,440,391 2,689 0 0 965,607 999,906 -497,743
Corporate Property Associates 18 Global (CPA18) 0% 5.9 4% 2,196,365 1,351,214 200,133 0 81,819 168,351 991,840
Freeze Tag (FRZT) 85% 14.2 -18% 595 1,098 1,562 1,334 -106 -15 -215
CAT9 (CAT9) 62% -0.7 55% 1,394 1,261 4,198 2,593 762 764 -546
Targa Resources Partners (NGLS) 27% 10.0 -0% 18,858,300 12,327,600 8,794,800 2,370,700 -41,100 678,100 6,807,800
Hospitality Investors Trust (HIT) -3% -25.4 -6% 2,295,473 1,643,623 606,893 -20,627 -127,678 -55,637 1,411,759
Vir Biotechnology (VIR) 0% 6.8 -11% 422,642 66,827 1,403 0 -48,314 -47,427 -320,200
Brisset Beer (BBII) 0% -0.5 -10,083% 1 129 8 0 -125 -77 40
United States Oil Fund (USO) -0% 3.3 -32% 1,429,808 45,816 -336,610 0 -451,799 -451,799 -1,495,037
Dragon Jade (DGJI) 0% 2,741 1,286 0 0 0 0 -483
Starco Brands (STCB) 0% 0.1 -53% 175 1,085 229 0 -93 -69 -5
Endless Charge (ENDL) 0.5 -184% 5 11 0 0 -10 -10 -5
Gulf & Orient Steamship (GLFO) 0.0 -118% 419 535 0 0 -497 -491 -19
Viela Bio (VIE) 3.2 -21% 233,840 493,500 0 0 -48,410 -48,410 -155,747
Liberty Media (LMCA) 0% 7.5 1% 43,645,000 21,467,000 9,682,000 0 358,000 1,869,000 13,948,000
Lvyuan Green Building Material Technology (LVYN) 0.0 0 144 0 0 -16 -16 -0

Balance Sheet ($'000)2013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash0000001209612530883256781225923535,9544,87211,97210,526
Accounts Receivable60785,150851
Inventory499871606747
PP&E3332333133339068921,5471,910
Assets0000002293135110140255181243223132153242,1102,10535,19839,40648,82846,503
Accounts Payable1121550577576726602661656510
Long-Term Debt3263639681,3804,0006,85718,61922,360
Liabilities811153037078811,1471,5331,2031,6862,2273,1603,2972,0182,1132,2163,4102,7336,3127,85917,33421,466
Stockholders' Equity-8-11-15-30-370-5-588-1,011-1,424-1,063-1,431-2,046-2,917-3,074-1,887-2,098-1,893-1,300-62828,88631,54831,49425,038
Income Statement ($'000)2013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue000000000000000000001,1791,9772,3732,930
Cost of Revenue000000000000000000007601,0471,4381,591
Gross Profit000000000000000000004199309341,339
R&D000000000000
SG&A0001111399518432740639617516314423721385838-31515,3922,9775,1033,000
Tax000000000000000000000000
Net Income-5-3-3-16-7-1-5-1,503-477-529-857-748-615-1,125-380-2,745-566-2,526-2,501-3,985-16,657-2,699-4,831-3,431
Cash Flow ($'000)2013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-5-3-3-3-15-777-295-232-345-280-378-309-211-283-184-241-484-516-3,810-4,013-394
Cash Investing-30-42-65-12-240000-2,0500-5,983-850-302
Cash Financing5333151,7821501953934023053551923551184882,29854615,69411,963-750